Literature DB >> 14998556

Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration.

Fariba Oveisi1, Silvana Gaetani, Kevin Tai-Pang Eng, Daniele Piomelli.   

Abstract

Oleoylethanolamide (OEA) is an endogenous lipid that contributes in important ways to the peripheral regulation of food intake. When administered intraperitoneally, OEA is a potent satiety-inducing anorexiant in rats and mice [Nature 414 (2001) 209; Neuropsycopharmacology 28 (2003) 1311; Nature 425 (2003) 90]. In the present study, we show that oral administration of OEA in pH-sensitive enteric-coated capsules produces a profound and long-lasting inhibition of food intake in free-feeding rats. This effect is accompanied by a marked elevation in OEA levels in the small intestine, but not in brain or muscle.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998556     DOI: 10.1016/j.phrs.2003.12.006

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  21 in total

Review 1.  The Macronutrients, Appetite, and Energy Intake.

Authors:  Alicia L Carreiro; Jaapna Dhillon; Susannah Gordon; Kelly A Higgins; Ashley G Jacobs; Breanna M McArthur; Benjamin W Redan; Rebecca L Rivera; Leigh R Schmidt; Richard D Mattes
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

Review 2.  Fat sensing and metabolic syndrome.

Authors:  Jang H Youn
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

3.  High-fat but not normal-fat intake of extra virgin olive oil modulates the liver proteome of mice.

Authors:  Isy F de Sousa; Amanda P Pedroso; Iracema S de Andrade; Valter T Boldarine; Alexandre K Tashima; Lila M Oyama; Lillà Lionetti; Eliane B Ribeiro
Journal:  Eur J Nutr       Date:  2020-07-25       Impact factor: 5.614

Review 4.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

5.  Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome.

Authors:  Miki Igarashi; Vidya Narayanaswami; Virginia Kimonis; Pietro M Galassetti; Fariba Oveisi; Kwang-Mook Jung; Daniele Piomelli
Journal:  Pharmacol Res       Date:  2016-12-19       Impact factor: 7.658

Review 6.  Gut microbiota and GLP-1.

Authors:  Amandine Everard; Patrice D Cani
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

7.  Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity.

Authors:  Zhongyi Chen; Lilu Guo; Yongqin Zhang; Rosemary L Walzem; Julie S Pendergast; Richard L Printz; Lindsey C Morris; Elena Matafonova; Xavier Stien; Li Kang; Denis Coulon; Owen P McGuinness; Kevin D Niswender; Sean S Davies
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

Review 8.  Biological functions and metabolism of oleoylethanolamide.

Authors:  Clémentine Thabuis; Delphine Tissot-Favre; Jean-Baptiste Bezelgues; Jean-Charles Martin; Cristina Cruz-Hernandez; Fabiola Dionisi; Frédéric Destaillats
Journal:  Lipids       Date:  2008-08-13       Impact factor: 1.880

9.  The lipid messenger OEA links dietary fat intake to satiety.

Authors:  Jin Fu; Giuseppe Astarita; Gary J Schwartz; Xiaosong Li; Silvana Gaetani; Patrizia Campolongo; Vincenzo Cuomo; Daniele Piomelli
Journal:  Cell Metab       Date:  2008-10       Impact factor: 27.287

10.  GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.

Authors:  Lina M Lauffer; Roman Iakoubov; Patricia L Brubaker
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.